ATP11C相关溶血性贫血的临床异质性:扩展表型与诊断谱
研究在7个无亲缘关系家系中鉴定出10例携带6种罕见新发ATP11C变异的个体,其中3种变异经功能验证显示ATP11C蛋白表达降低及翻转酶活性下降,支持功能丧失机制。一例女性患者存在X染色体失活偏移使杂合变异产生临床效应。研究扩展了ATP11C相关溶血性贫血的临床谱,提示其与成人发病及肝脏铁过载相关,建议将ATP11C纳入遗传性溶血性贫血及铁代谢异常的基因检测。
要点
- ATP11C变异可导致X连锁先天性溶血性贫血,表现从新生儿轻度贫血到成人发病不等。
- 一例男性患者最初被怀疑遗传性血色病,提示ATP11C相关贫血可伴肝脏铁过载。
- 女性杂合子可因X染色体失活偏移而出现临床表型。
核心结论
- ATP11C相关溶血性贫血具有显著临床异质性,可表现为新生儿轻度贫血、成人发病及肝脏铁过载。
- ATP11C变异通过降低蛋白表达和翻转酶活性导致功能丧失。
- 女性杂合子可因X染色体失活偏移而显现致病效应。
研究设计与样本
- 研究纳入7个无亲缘关系家系中的10例携带ATP11C罕见新发变异的个体。
- 共鉴定出6种罕见新发ATP11C变异,其中3种进行了功能验证。
主要发现
- 变异p.R467C见于一名表现为轻度溶血性贫血的男性新生儿。
- 变异c.2226-1G>C见于一名53岁男性,最初被怀疑遗传性血色病。
- 变异p.D609V见于一名68岁女性,表现为轻度贫血。
- 功能研究显示ATP11C蛋白表达降低及体外和离体红细胞中翻转酶活性下降。
- 女性患者中检出X染色体失活偏移,使杂合ATP11C变异的致病效应在临床上显现。
关键数值与推荐
- 3种变异经功能验证显示ATP11C蛋白表达降低及翻转酶活性下降,支持功能丧失机制。
- 女性患者存在X染色体失活偏移,使杂合变异产生临床效应。
临床怎么用
- 对遗传性溶血性贫血及铁代谢异常患者,基因检测应包含ATP11C。
- 对疑似遗传性血色病但表现不典型者,需考虑ATP11C相关溶血性贫血可能。
- 女性杂合子出现贫血时需考虑X染色体失活偏移导致的临床显现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ATP11C gene, localized on the X chromosome, encodes the major phosphatidylserine flippase in human red blood cells (RBCs). Flippases actively transport phospholipids from the outer to the inner leaflet of the lipid bilayer, establishing and maintaining phospholipid asymmetry crucial for cell survival. Variants in ATP11C have been recently associated with a novel form of X-linked congenital hemolytic anemia. In this study, we identified 10 individuals from 7 unrelated families harboring 6 rare, novel variants in the ATP11C gene. Three of the variants were further characterized and functionally validated. Of note, the first variant, p.R467C, was identified in a male neonate presenting with mild hemolytic anemia. The second variant, c.2226-1G>C, was found in a male aged 53 years who was originally suspected of hereditary hemochromatosis. The third variant, p.D609V, was detected in a female aged 68 years with mild anemia. Functional studies revealed reduced ATP11C protein expression, as well as decreased flippase activity both in vitro and in ex vivo RBCs supporting a loss-of-function mechanism. Additionally, in the female patient, we identified skewed X-chromosome inactivation, because of which the pathogenic effect of the heterozygous ATP11C variant became clinically evident. Our study expands the clinical spectrum of ATP11C-related hemolytic anemia, highlighting its association with adult-onset disease and hepatic iron overload. We emphasize the importance of including ATP11C in genetic testing for the diagnosis of hereditary hemolytic anemia and iron metabolism alterations. These findings enhance our understanding of RBCs membrane homeostasis and elucidate the critical role of ATP11C in erythropoiesis and systemic iron regulation.
引用
- D'Onofrio V, Esposito FM, Marra R, et al. Clinical variability of ATP11C-related hemolytic anemia: expanding the phenotypic and diagnostic spectrum. Blood Adv. 2026. PMID: 42018644. doi:10.1182/bloodadvances.2025019161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。